Koj puas tau pom koj tus dev uas koj hlub raug mob khaus thiab tsis xis nyob vim ua xua rau ntawm daim tawv nqaij? Nrhiav kev pab sai? Kawm txog cov khoom no, tsim los muab kev pab sai thiab zoo los ntawm kev khaus thiab khaus cuam tshuam nrog canine atopic dermatitis. Kab lus no yuav tshawb xyuas cov txheej txheem ntawm kev nqis tes ua, cov txiaj ntsig, thiab kev siv tswv yim ntawm oclacitinib maleate hauv cov tshuaj kho tsiaj.
Dab tsi yog Oclacitinib Maleate Mechanism of Action
Oclacitinib maleate hmoovyog Malate ntsev daim ntawv ntawm oclacitinib, ib tug hluavtaws Janus kinase (JAK) inhibitor. Hauv cov tshuaj kho tsiaj, nws feem ntau cuam tshuam nrog kev tswj cov kab mob pruritus, lossis khaus, cuam tshuam rau kev ua xua dermatitis thiab atopic dermatitis hauv dev. Lub US FDA daim ntawv lo qhia Apoquel ua ib qho tshuaj tiv thaiv kab mob thiab qhia nws siv rau cov dev tsawg kawg yog 12 lub hlis ntawm hnub nyoog.
Tus yuam sij kom nkag siab txog nws txoj haujlwm yog JAK-STAT txoj kev taw qhia. Cytokines yog cov cim qhia cov protein uas pab tswj kev tiv thaiv kab mob thiab kab mob. Qee cov cytokines cuam tshuam nrog kev ua xua, o, thiab khaus kis lawv cov cim los ntawm JAK enzymes.
Oclacitinib inhibits cov cim qhia txog JAK1 thiab JAK3, yog li txo cov kev ua ntawm ntau cytokines koom nrog hauv kev ua xua thiab pruritic teb. Nws muaj kev sib piv me ntsis ntawm cytokines koom nrog hauv hematopoiesis uas nyob ntawm JAK2.
Cov txheej txheem no pab piav qhia tias yog vim li cas oclacitinib tuaj yeem txo qhov khaus yam tsis tau muab cais ua corticosteroid lossis antihistamine. Kev tshawb fawb tau txuam nrog JAK1 / STAT txoj kev inhibition nrog txo cov teeb liab los ntawm cytokines xws li IL-2, IL-4, IL-6, IL-13, thiab IL-31, uas cuam tshuam rau txoj kev ua xua thiab atopic dermatitis.
Hauv cov ntsiab lus, oclacitinib lub hom phiaj intracellular cytokine signaling, es tsis yog tsuas yog thaiv cov histamine receptors los yog broadly suppressing o los ntawm steroid pathways.Yog hais tias koj xav kawm ntxiv txog oclacitinib maleate, thov hu rau Xi'an Sonwu.
Dab tsi yog Oclacitinib Maleate siv rau, thiab nws txawv ntawm Apoquel li cas
Oclacitinib maleate feem ntau yog siv hauv cov tshuaj kho tsiaj los pab tswj cov kab mob pruritus txuam nrog kev tsis haum dermatitis thiab kev kho mob ntawm atopic dermatitis hauv dev. FDA- pom zoo daim ntawv lo qhia txog kev siv qhov ncauj hauv dev thiab suav nrog kev txwv hnub nyoog thiab kev nyab xeeb.
Oclacitinib Maleate vs. Apoquel
Rau ntau lub hom phiaj, oclacitinib maleate thiab Apoquel tsis yog ob hom tshuaj sib txawv.
Apoquel yog ib hom khoom lag luam -npe veterinary khoom uas nws muaj active ingredient yog oclacitinib, formulated raws li oclacitinib maleate. FDA cov ntaub ntawv pov thawj tseem teev cov oclacitinib maleate thiab Apoquel nyob rau hauv kev sib txuas nrog tib yam tshuaj active tshuaj.
Qhov sib txawv yog li ntawd feem ntau yog ib qho ntawm terminology:
Oclacitinib maleate - cov khoom siv tshuaj nquag / daim ntawv siv hauv cov khoom.
Apoquel - ib hom tshuaj veterinary uas muaj oclacitinib.
Apoquel Chewable - chewable formulation muaj oclacitinib.
Thawj Apoquel muaj nyob rau hauv cov ntsiav tshuaj coated, thaum Apoquel Chewable sawv cev rau ntau hom tshuaj. Tam sim no FDA daim ntawv lo txheeb xyuas ob yam khoom raws li cov tshuaj kho tsiaj uas muaj oclacitinib.
Qhov kev sib txawv no yog qhov tshwj xeeb tshaj yog thaum sib tham txog cov khoom siv tshuaj, kev tsim kho, kev tshuaj ntsuam xyuas, lossis kev tsim tshuaj veterinary. Ib qho kev siv rau "oclacitinib maleate" feem ntau cuam tshuam txog cov khoom xyaw nquag, thaum "Apoquel" yog hais txog cov khoom lag luam tiav.
Siv rau khaus
Kev khaus khaus cuam tshuam nrog cov kab mob ua xua ntawm daim tawv nqaij muaj kev sib txuas ntawm kev tiv thaiv kab mob. Histamine tsuas yog ib feem ntawm lub network no. Cytokines thiab lawv cov kev taw qhia qis qis tuaj yeem ua rau muaj txiaj ntsig zoo rau kev hnov mob pruritus.
Vim hais tias oclacitinib cuam tshuam nrog JAK- nyob ntawm cytokine signaling, nws tuaj yeem hais txog cov teeb meem tseem ceeb uas cuam tshuam nrog kev ua xua khaus. Qhov no yog ib qho laj thawj uas nws cov tshuaj pharmacological txawv ntawm cov tshuaj antihistamines.
Puas yog Oclacitinib Maleate yog Antihistamine lossis Steroid?
Tsis yog. Oclacitinib maleate tsis yog ib qho tshuaj tiv thaiv kab mob lossis tshuaj steroid.Qhov no yog ib qho tseem ceeb tshaj plaws thaum muab piv rau cov kws kho tsiaj rau cov kab mob ua xua. Cov ntaub ntawv ntawm cov khoom lag luam qhia meej meej tias oclacitinib tsis yog corticosteroid thiab tsis yog tshuaj tiv thaiv.
Oclacitinib vs. Antihistamines
Antihistamines feem ntau ua haujlwm los ntawm kev thaiv cov tshuaj histamine, tshwj xeeb yog H1 receptors, yog li txo cov teebmeem ntawm histamine.
Oclacitinib siv lwm txoj hauv kev. Nws inhibits JAK-nyob ntawm cov teeb liab cuam tshuam nrog ntau yam pruritogenic thiab pro-inflammatory cytokines. Yog li ntawd, nws lub hom phiaj pharmacological yog qhov txawv ntawm cov tshuaj antihistamine.
Oclacitinib vs. Corticosteroids
Corticosteroids cuam tshuam rau ntau yam kab mob thiab kev tiv thaiv kab mob thiab tuaj yeem tsim cov tshuaj tiv thaiv kab mob. Oclacitinib, los ntawm kev sib piv, yog lub hom phiaj JAK inhibitor uas hloov cov kev xaiv cytokine signaling.
Qhov no tsis tau txhais hais tias oclacitinib tsis muaj kev saib xyuas kev nyab xeeb. Vim tias nws hloov kho lub cev tiv thaiv kab mob, FDA daim ntawv lo ceeb toom tias nws yuav ua rau muaj kev kis kab mob ntau ntxiv thiab tsis yog rau cov dev uas muaj kab mob hnyav. Qee yam mob neoplastic kuj tau raug tshaj tawm thaum lub sij hawm soj ntsuam thiab tom qab- pom zoo siv.
Vim li no, oclacitinib- muaj cov tshuaj kws kho tsiaj yuav tsum tau siv raws li kev saib xyuas kws kho tsiaj uas tsim nyog es tsis yog kho raws li kev hloov pauv nrog ntau dua -cov khoom lag luam tshuaj tiv thaiv kab mob.
Los ntawm kev xav txog tshuaj thiab kws kho tsiaj, kev nkag siab txog qhov sib txawv no kuj tseem ceeb thaum ntsuas tus kheej, purity, formulation compatibility, analytical specifications, thiab zoo sib xws ntawm oclacitinib maleate.
Rau cov koom haum tshawb fawb oclacitinib maleate rau veterinary pharmaceutical development, analytical research, or ingredient sourcecing, xaiv cov khoom uas muaj cov ntsiab lus qhia meej meej thiab cov ntaub ntawv pov thawj zoo yog ib feem tseem ceeb ntawm kev tsim cov dej hauv qab thiab zoo - tswj kev ua haujlwm. Cov tuam txhab txaus siab rau oclacitinib maleate raw cov ntaub ntawv tuaj yeem ntsuas cov lus qhia tshwj xeeb, cov ntaub ntawv xeem, thiab muab peev xwm nrog cov khoom tsim nyog cov khoom lag luam. lub oclacitinib maleate mechanism ntawm kev txiav txim yog nyob rau ntawm JAK- nyob ntawm cytokine signaling. Nws yog siv feem ntau los tswj kev ua xua thiab atopic dermatitis-assoc
Rau kev tshawb fawb tshuaj, kev tsim kho tsiaj, lossis kev tsim khoom, cov tuam txhab xav tau oclacitinib maleate hmoov tuaj yeem tiv tauj Xi'an Sonwu rau cov khoom tshwj xeeb, cov ntaub ntawv zoo, tus nqi, thiab cov ntaub ntawv muab.
Email:sales@sonwu.com